Form4.ai tracks every SEC insider trade in real time. See every DNTH insider filing with a free account — no card.
See every DNTH insider filing — free account, no card.
Free accountDianthus Therapeutics, Inc. (DNTH) has 7 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 18, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 18, 2026 SEC filing | CARR EDWARD CHIEF ACCOUNTING OFFICER | Cashless exercise | $1,670,046 | — |
| Sep 3, 2026 SEC filing | Randhawa Simrat EVP, Head of R&D | Cashless exercise | $2,047,233 | — |
| Aug 19, 2026 SEC filing | Read Simon Director | Cashless exercise | $275,550 | — |
Create a free account to see all 7 DNTH filings from the last 90 days. No card needed.
Create free accountWant DNTH insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.